Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Grand Pharmaceutical Group Limited ( (HK:0512) ) has shared an announcement.
Grand Pharmaceutical Group Limited announced its upcoming Annual General Meeting (AGM) to be held on April 10, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks approval for directors to allot and issue shares, with limitations on the aggregate number of shares to be issued. These resolutions aim to strengthen the company’s governance and financial strategies, potentially impacting its market position and shareholder value.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating within the pharmaceutical industry. It is listed on the Stock Exchange of Hong Kong and focuses on the development, production, and distribution of pharmaceutical products.
YTD Price Performance: 27.29%
Average Trading Volume: 5,721,817
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$21.44B
For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.